Skylands Capital, LLC Haemonetics Corp Transaction History
Skylands Capital, LLC
- $660 Million
- Q4 2024
A detailed history of Skylands Capital, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Skylands Capital, LLC holds 27,175 shares of HAE stock, worth $1.61 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
27,175
Previous 23,300
16.63%
Holding current value
$1.61 Million
Previous $1.87 Million
13.3%
% of portfolio
0.32%
Previous 0.27%
Shares
2 transactions
Others Institutions Holding HAE
# of Institutions
337Shares Held
54.3MCall Options Held
689KPut Options Held
345K-
Black Rock Inc. New York, NY5.96MShares$354 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$307 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.44MShares$264 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$249 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY4.03MShares$239 Million0.26% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.05B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...